Zusammenfassung
In Deutschland ist jeder zweite Mensch übergewichtig. Problematisch ist besonders die Behandlung von morbid übergewichtigen Pateinten, da bei diesen konservative Maßnahmen häufig fehlschlagen. Die Behandlung dieser Patientengruppe mit Verfahren der bariatrischen Chirurgie kann langfristig gute Ergebnisse in Bezug auf eine nachfolgende Gewichtsabnahme und Verminderung der begleitenden Komorbidität aufweisen. Obligatorisch ist eine strukturierte Nachsorge im Hinblick auf die medizinisch psychologischen Auswirkungen sowie die Notwendigkeit der Erkennung von operationsbedingten Mangelzuständen bei Vitaminen und Mineralien sowie eine Anpassung der Pharmakotherapie.
Abstract
Every second person in Germany is overweight. In patients with morbid obesity, conservative therapeutic measures often fail. Bariatric surgery can induce good long-term results with respect to loss of bodyweight and reduction of concomitant comorbidity in this patient group. To detect operation-induced deficiencies in minerals, vitamins as well as drug and hormone concentrations and to objectify the medical/psychological changes in the patient, a structured follow-up is mandatory. Adaption of pharmacotherapy, especially with respect to diabetes medication, is necessary.
Literatur
Baker KB, Palekar NA, Bowers SP et al (2006) Non-alcoholic steatohepatits: effect of Roux-en-Y gastric bypass surgery. Am J Gastroenterol 101:368–373
Bloomberg RD, Fleishman A, Nalle JE et al (2005) Nutritional deficiencies following bariatric surgery: What have we learned. Obes Surg 15:145–154
Buchwald H, Avidor Y, Braunwald E et al (2004) Bariatric surgery: a systematic review and mataanalysis. JAMA 292:1724–1737
Carson JL, Ruddy ME, Duff AE et al (1994) The effect of gastric bypass surgery on hypertension in morbidly obese patients. Arch Intern Med 154:1770
Cizmecioglu FM, Etiler N, Ergen A et al (2009) Association of adiponectin, resistin and high sensitive CRP level with the metabolic syndrome in childhood and adolescence. Exp Clin Endocrinol Diabetes 117:622–627
Courcoulas A, Perry Y, Buenaventura P, Luketich J (2003) Comparing the outcomes after laparoscopic versus open gastric bypass: a matched paired analysis. Obes Surg 13:341–346
Courcoulas A, Schuchert M, Gatti G, Luketich J (2003) The relationship of surgeon and hospital volume to outcome after gastric bypass surgery in Pennsylvania: a 3-year summary. Surgery 134:613–621
Cummings DE, Overduin J, Foster-Schubert KE et al (2007) Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis 3:109–115
Cumming DE, Overduin J, Foster-Schubert KE et al (2007) Gastric bypass for obesity mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 89:2608–2615
Cummings PM, Le BH Lopes MB (2007) Postmortem findings in morbidly obese individuals dying after gastric bypass procedures. Hum Pathol 38:593–597
Dixon JB (2007) surgical treatment for obesity and its impact on non-alcoholic steatohepatitis. Clin Liver Dis 1:141–154
Eid GM, Cottam DR, Velcu LM et al (2005) Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis 1:77–80
Evidenzbasierte Leitlinie Therapie und Präventation der Adipositas (DAG, DDG) 2007
Fontaine KR, Redden DT, Wang C et al (2003) Years of life lost due to obesity. JAMA 289:187–193
Giusti V, Navarro C, Suter M et al (1999) Indications for gastroplasty in the treatment of obesity. Rev Med Suisse Romande 119:469–474
Hooper MM, Stellato TA, Hallowell PT et al (2007) Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int J Obes (Lond) 31:114–120
Maggard MA, Yermilov I, Li Z et al (2008) Pregnancy and fertility following bariatric surgery: a systematic review. JAMA 300:2286–2296
Malinowski S (2006) Nutritional and metabolic complications of bariatric surgery. Am J Med Sci 331:219–225
Marcus MD, Kalarchian MA, Courcoulas AP (2009) Psychiatric evaluation and follow-up of bariatric surgery patients. Am J Psychiatry 166:285–291
Makary MA, Clarke JM, Shore AD et al (2010) Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery. Arch Surg 145:726–731
McCloskey CA, Ramani GV, Mathier MA et al (2007) Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis 3:503–507
National Institutes of health (1992) National institute of health consensus development conference statement. Am J Clin Nutr 55:487–619
Raab H, Weiner R (2010) Ernährung, Mangelerscheinungen und Supplemente. In: Weiner R (Hrsg) Adipositaschirurgie. Urban & Fischer, S 294
Scopinaro N, Marinari G, Camerini G et al (2005) Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow up study. Diabetes Care 28:2406–2411
Sjöström L, Lindroos AK, Peltonen M et al (2004) Lifestyle diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 3:2683–2693
Sjöström L, Narbro K, Sjöström CD et al (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741–752
Society of America Gastrointestinal Endoscopic Surgeons (2003) Guidelines for institutions granting bariatric privileges utilizing laparoscopic techniques. Society of America Gastrointestinal Endoscopic Surgeons (SAGES) and the SAGES Bariatric Task Force. Surg Endosc17:2037–2040
Statistisches Bundesamt, Microzensus 2009 – Fragen zur Gesundheit, unveröffentlicht
Still CD, Benotti P, Wood GC, Gerhard GS et al (2007) Outcomes of preoperative weight loss in high-risk patients undergoing gastric bypass surgery. Arch Surg 142:994–998
Sugerman HJ, Brewer WH, Shiffman ML et al (1995) A multicenter, placebo-controlled, randomized, double-blind, prospective trail of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 169:91–96
Suter MP (2005) Checkliste Ernährung, Physiologische Grundlagen, Seite 8, Abb. 2
S3-Leitlinie Chirurgie der Adipositas (DGAV, DAG, DGEM) 2010
Tamakoshi K, Yatsuya H, Kondo T et al (2003) The metabolic syndrome is associated with elevated circulating C-reaktive protein in healthy reference range a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 27:443–449
Wechsler JG (2010) 35:1–3
Weiner R (2009) Finanzierung der Adipositaschirurgie, In: Adipositaschirurgie – Indikation und Therapieverfahren. S 165
Wudel LJ Jr, Wright JK, Debelak JP et al (2002) Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res 102:50–56
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rosak, C. Bariatrische Chirurgie bei morbider Adipositas. Diabetologe 6, 630–636 (2010). https://doi.org/10.1007/s11428-010-0622-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11428-010-0622-7